Clinical Trials Browser

Phase NA × Interventional × Erlotinib Hydrochloride × Clear all

NCT02194738 2026-05-13

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Phase NA Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00883480 2026-04-28

SLAT

Phase NA Completed

Carcinoma, Non-Small-Cell Lung

NCT01683422 2021-08-10

Chemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic Cancer

Phase NA Terminated

9 enrolled 8 charts

Gastrointestinal

Pancreatic Neoplasms

NCT01636908 2021-04-15

ICK

Phase NA Completed

Neoplasms

NCT01190241 2020-11-20

TSAP

Phase NA Terminated

Neoplasm Metastasis

NCT02239952 2020-10-08

HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)

Phase NA Unknown

Glioma, Neoplasms

NCT04007835 2019-07-05

Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKI

Phase NA Unknown

NSCLC

NCT00503841 2019-04-30

Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer

Phase NA Terminated

44 enrolled 3 charts

Breast Neoplasms

NCT00125372 2019-01-08

Study of Tarceva and Targretin in Stage I-II Lung Cancer

Phase NA Completed

12 enrolled 10 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT02450591 2018-05-21

Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations

Phase NA Completed

4 enrolled 7 charts

Oligometastatic Lung Adenocarcinoma

NCT02015728 2016-12-15

SEED

Phase NA Unknown

Neoplasms, Recurrence

NCT02013089 2016-08-30

GITIC

Phase NA Unknown

Gastrointestinal

Gastrointestinal Neoplasms

NCT00144976 2015-03-27

Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma

Phase NA Completed

Head and Neck Neoplasms

NCT00085280 2014-03-31

Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Phase NA Completed

Carcinoma, Non-Small-Cell Lung

NCT01776684 2013-01-28

Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis

Phase NA Unknown

EGFR Mutation Positive Non-small Cell Lung Cancer

NCT00903292 2009-05-18

Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung